Due to the central role of the PI3K/AKT signaling pathway in the initiation and progression of EC, and the evidence that multiple tumor-associated genes regulate this pathway in the context of EC, the AKT signaling axis was selected as the focus of this study, based on findings from bioinformatics analysis combined with phospho-protein array profiling. The gene discussed is AKT1; the disease is neoplasm.